Dbl family RhoGEFs in cancer: different roles and targeting strategies
Biochemical Pharmacology · 2024
DOI: 10.1016/j.bcp.2024.116141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Xin-Yi Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Tradi…. Hauptthemen laut MEDLINE: Neoplasms, Lymphoma, B-Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 137 Literaturangaben.
Abstract (Originalsprache)
Small Ras homologous guanosine triphosphatase (Rho GTPase) family proteins are highly associated with tumorigenesis and development. As intrinsic exchange activity regulators of Rho GTPases, Rho guanine nucleotide exchange factors (RhoGEFs) have been demonstrated to be closely involved in tumor development and received increasing attention. They mainly contain two families: the diffuse B-cell lymphoma (Dbl) family and the dedicator of cytokinesis (Dock) family. More and more emphasis has been paid to the Dbl family members for their abnormally high expression in various cancers and their correlation to poor prognosis. In this review, the common and distinctive structures of Dbl family members are discussed, and their roles in cancer are summarized with a focus on Ect2, Tiam1/2, P-Rex1/2, Vav1/2/3, Trio, KALRN, and LARG. Significantly, the strategies targeting Dbl family RhoGEFs are highlighted as novel therapeutic opportunities for cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- School of Biological Engineering, Tianjin University of Science&Technology, Tianjin 301617, China.
- Department of Pharmacy, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
- Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: j…
- Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: l…
- Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: z…
Zitieren
APA
Chen, X. Y., Cheng, A. Y., Wang, Z. Y., Jin, J. M., Lin, J. Y., Wang, B., Guan, Y. Y., Zhang, H., Jiang, Y. X., Luan, X., & Zhang, L. J. (2024). Dbl family RhoGEFs in cancer: different roles and targeting strategies. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116141
Vancouver
Chen XY, Cheng AY, Wang ZY, Jin JM, Lin JY, Wang B, et al. Dbl family RhoGEFs in cancer: different roles and targeting strategies. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116141
BibTeX
@article{Chen2024,
author = {Chen, Xin-Yi and Cheng, Ao-Yu and Wang, Zi-Ying and Jin, Jin-Mei and Lin, Jia-Yi and Wang, Bei and Guan, Ying-Yun and Zhang, Hao and Jiang, Yi-Xin and Luan, Xin and Zhang, Li-Jun},
title = {Dbl family RhoGEFs in cancer: different roles and targeting strategies},
journal = {Biochemical Pharmacology},
year = {2024},
doi = {10.1016/j.bcp.2024.116141}
}
EUVIMED